Sai Parenteral's IPO Day 2: Check GMP, subscription status, and more - Apply or not?

-47.6

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

A very low subscription rate and zero GMP are strong indicators of a lack of demand and potential for a discounted listing, making it unattractive for short-term gains.

Trading Insight

Do not apply for this IPO; the risk of capital erosion on listing is high.

Quick check: TATASTEEL neutral (+2.3% 1d), HINDALCO bearish bias (+1.4% 1d).

Key Evidence

•Sai Parenteral's IPO subscription is only 0.05 times by Day 2.
•The price band is ₹372-392.
•The grey market premium (GMP) is ₹0.
•Risk flag: Extremely low subscription indicates lack of investor confidence
•Risk flag: Zero GMP suggests no listing gains are anticipated

Sectors:metals

AI-powered analysis by

Anadi Algo News